Parma, Italy

Rossella Musa

USPTO Granted Patents = 17 


 

Average Co-Inventor Count = 4.1

ph-index = 6

Forward Citations = 228(Granted Patents)


Company Filing History:


Years Active: 2003-2020

Loading Chart...
Loading Chart...
Loading Chart...
17 patents (USPTO):Explore Patents

Title: Rossella Musa: Innovator in Pharmaceutical Formulations

Introduction

Rossella Musa is a prominent inventor based in Parma, Italy, known for her significant contributions to the field of pharmaceutical formulations. With a total of 17 patents to her name, she has made remarkable advancements in the development of inhalable medications.

Latest Patents

Among her latest patents is the invention of tobramycin magnesium stearate microparticles for inhalation. This innovative formulation is designed to treat bacterial infections associated with certain pulmonary diseases. Additionally, she has developed a method for making composite excipient particles for use in pharmaceutical compositions. This method involves a milling step that allows for the production of small-sized particles with relatively low input of time and energy, making them suitable for inhalable pharmaceutical compositions.

Career Highlights

Throughout her career, Rossella has worked with notable companies in the pharmaceutical industry, including Chiesi Farmaceutici S.p.a. and Vectura GmbH. Her work has focused on enhancing the efficacy and delivery of medications, particularly in the area of respiratory treatments.

Collaborations

Rossella has collaborated with esteemed colleagues such as John Nicholas Staniforth and David Alexander Vodden Morton, contributing to the advancement of pharmaceutical sciences through teamwork and shared expertise.

Conclusion

Rossella Musa's innovative work in pharmaceutical formulations has significantly impacted the treatment of pulmonary diseases. Her dedication to research and development continues to pave the way for new therapeutic options in the medical field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…